About the journal
mAbs is an open-access journal published by Taylor & Francis Group in United Kingdom, publishing in english. It is listed in DOAJ and MEDLINE and PUBMED according to the sources read. Declared publication charge: 6,110 AUD. Declared review time at DOAJ: 8 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Taylor & Francis Group
- ISSN
- 1942-0862 · 1942-0870
- Country
- United Kingdom
- Languages
- english
- Access
- Open access
- Declared publication charge
- 6,110 AUD
- Articles in DOAJ
- 728
- Declared review time
- 8 weeks
- Declared peer-review model
- peer_review
- Official website
- https://www.tandfonline.com/journals/kmab
Index listings
- DOAJ · 2021-05-10
- MEDLINE · 2009-01-01
- PUBMED · 2010-05-17
- Indexing
- DOAJ · MEDLINE · PUBMED
- APC
- 6,110 AUD
- Declared review time (DOAJ)
- 8 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
728
Most recent article
last month
Average review time (journal-declared via DOAJ)
8weeks
Works in OpenAlex
1899
Last recorded publication year
2026
h-index
127
i10-index
1384
From OpenAlex open data (CC0).
Editorial & policy13
- Last DOAJ review date
- 2024-08-08
- Added to DOAJ
- 2021-05-10
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSLOCKSSPMCPortico
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 96%
- ORCID iDs in current deposits
- 75%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity3
- Alternate titles
- Monoclonal antibodies
- Source type
- journal
- NLM unique ID (PubMed)
- 101479829
Classification4
Subjects (DOAJ)
LCC codes
Subject areas
- Monoclonal and Polyclonal Antibodies Research
- Monoclonal and Polyclonal Antibodies Research
- Protein purification and stability
- Protein purification and stability
- Glycosylation and Glycoproteins Research
- Glycosylation and Glycoproteins Research
- Viral Infectious Diseases and Gene Expression in Insects
- Viral Infectious Diseases and Gene Expression in Insects
Show all subjects (50)
- CAR-T cell therapy research
- CAR-T cell therapy research
- Biosimilars and Bioanalytical Methods
- Biosimilars and Bioanalytical Methods
- T-cell and B-cell Immunology
- T-cell and B-cell Immunology
- HER2/EGFR in Cancer Research
- HER2/EGFR in Cancer Research
- Immunotherapy and Immune Responses
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune Cell Function and Interaction
- Transgenic Plants and Applications
- Transgenic Plants and Applications
- Chronic Lymphocytic Leukemia Research
- Chronic Lymphocytic Leukemia Research
- vaccines and immunoinformatics approaches
- vaccines and immunoinformatics approaches
- Advanced Biosensing Techniques and Applications
- Galectins and Cancer Biology
- Advanced Biosensing Techniques and Applications
- Galectins and Cancer Biology
- Toxin Mechanisms and Immunotoxins
- Toxin Mechanisms and Immunotoxins
- Cell Adhesion Molecules Research
- Cell Adhesion Molecules Research
- Immunodeficiency and Autoimmune Disorders
- Immunodeficiency and Autoimmune Disorders
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
- SARS-CoV-2 and COVID-19 Research
- SARS-CoV-2 and COVID-19 Research
- Peptidase Inhibition and Analysis
- Complement system in diseases
- Complement system in diseases
- Peptidase Inhibition and Analysis
- Mass Spectrometry Techniques and Applications
- Mass Spectrometry Techniques and Applications
- Nanofabrication and Lithography Techniques
- Lymphoma Diagnosis and Treatment
- Lymphoma Diagnosis and Treatment
- Nanofabrication and Lithography Techniques
Keywords (DOAJ)
- immunology
- antibodies
- cancer
- antibody therapeutics
- antibody engineering
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ